Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Data Brief ; 7: 1598-601, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27222860

ABSTRACT

Inherent ʟ-Ser deficiency culminates in intrauterine growth retardation, severe malformation of multiple organs particularly the central nervous system, and perinatal or early postnatal death in human and mouse. To uncover the molecular mechanisms underlying the growth-arrested phenotypes of l-Ser deficiency, we compared gene expression profiles of mouse embryonic fibroblasts deficient in 3-phosphoglycerate dehydrogenase (Phgdh), the first enzyme of de novo ʟ-Ser synthetic pathway, between ʟ-Ser-depleted and -supplemented conditions. The datasets (CEL and CHP files) from this study are publicly available on the Gene Expression Omnibus repository (accession number GEO: GSE55687).

2.
FEBS Open Bio ; 6(4): 303-16, 2016 04.
Article in English | MEDLINE | ID: mdl-27239443

ABSTRACT

UNLABELLED: Reduced availability of l-serine limits cell proliferation and leads to an adaptation to l-serine-deficient environment, the underlying molecular mechanism of which remain largely unexplored. Genetic ablation of 3-phosphoglycerate dehydrogenase (Phgdh), which catalyzes the first step of de novo l-serine synthesis, led to diminished cell proliferation and the activation of p38 MAPK and stress-activated protein kinase/Jun amino-terminal kinase in mouse embryonic fibroblasts under l-serine depletion. The resultant l-serine deficiency induced cyclin-dependent kinase inhibitor 1a (Cdkn1a; p21) expression, which was mediated by p38 MAPK. Survival of the Phgdh-deficient mouse embryonic fibroblasts was markedly reduced by p38 MAPK inhibition under l-serine depletion, whereas p38 MAPK could be activated by 1-deoxysphinganine, an atypical alanine-derived sphingoid base that was found to accumulate in l-serine-depleted mouse embryonic fibroblasts. These observations provide persuasive evidence that when the external l-serine supply is limited, l-serine synthesized de novo in proliferating cells serves as a metabolic gatekeeper to maintain cell survival and the functions necessary for executing cell cycle progression. DATABASE: Gene Expression Omnibus, accession number GSE55687.

3.
FEBS J ; 280(6): 1502-17, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23350942

ABSTRACT

Targeted disruption in mice of the gene encoding D-3-phosphoglycerate dehydrogenase (Phgdh) results in embryonic lethality associated with a striking reduction in free L-serine and growth retardation including severe brain malformation. We previously observed a severe impairment in neurogenesis of the central nervous system of Phgdh knockout (KO) embryos and a reduction in the protein content of their brains. Although these findings suggest that L-serine deficiency links attenuation of mRNA translation to severe developmental malformation of the central nervous system, the underlying key molecular event remains unexplored. Here we demonstrate that mRNA of Eif4ebp1 encoding eukaryotic initiation factor 4 binding protein 1 and its protein, 4E-BP1, are markedly induced in the central nervous system of Phgdh KO embryos, whereas a modest induction is observed in the liver. The increase in 4E-BP1 was associated with a decrease in the cap initiation complex in the brain, as shown by lower levels of eukaryotic translation initiation factor 4G bound to eukaryotic translation initiation factor 4E (eIF4E) and increased eIF4E interaction with 4E-BP1 based on 7-methyl-GTP chromatography. eIF4E protein and polysomes were also diminished in Phgdh KO embryos. Induction of Eif4ebp1 mRNA and of 4E-BP1 was reproduced in mouse embryonic fibroblasts established from Phgdh KO embryos under the condition of L-serine deprivation. Induction of Eif4ebp1 mRNA was suppressed only when L-serine was supplemented in the culture medium, indicating that reduced L-serine availability regulates the induction of Eif4ebp1/4E-BP1. These data suggest that elevated levels of 4E-BP1 may be involved in a mechanism to arrest brain development in Phgdh KO embryos.


Subject(s)
Brain/pathology , Carrier Proteins/metabolism , Peptide Chain Initiation, Translational , Phosphoglycerate Dehydrogenase/genetics , Phosphoproteins/metabolism , Repressor Proteins/metabolism , Serine/deficiency , Adaptor Proteins, Signal Transducing , Animals , Blotting, Western , Brain/embryology , Brain/metabolism , Carrier Proteins/genetics , Cell Cycle Proteins , Culture Media/metabolism , Dose-Response Relationship, Drug , Embryo, Mammalian/metabolism , Embryo, Mammalian/pathology , Embryonic Development , Eukaryotic Initiation Factor-4G/genetics , Eukaryotic Initiation Factor-4G/metabolism , Eukaryotic Initiation Factors , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Gene Deletion , Gene Expression Regulation, Developmental , Liver/metabolism , Liver/pathology , Mice , Mice, Knockout , Neuroglia/metabolism , Neuroglia/pathology , Organ Size , Phosphoproteins/genetics , Polyribosomes/genetics , Polyribosomes/metabolism , Protein Interaction Mapping , RNA Stability , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, Notch1/genetics , Receptor, Notch1/metabolism , Repressor Proteins/genetics , Serine/genetics , Serine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...